Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 75.01M P/E - EPS this Y 18.60% Ern Qtrly Grth -
Income -24.99M Forward P/E -3.17 EPS next Y 3.50% 50D Avg Chg 3.00%
Sales 2.84M PEG - EPS past 5Y - 200D Avg Chg 11.00%
Dividend N/A Price/Book 2.30 EPS next 5Y - 52W High Chg -25.00%
Recommedations 2.00 Quick Ratio 0.59 Shares Outstanding 37.82M 52W Low Chg 94.00%
Insider Own 51.93% ROA -42.68% Shares Float 17.84M Beta 0.98
Inst Own 2.82% ROE -98.23% Shares Shorted/Prior 15.87K/23.96K Price 2.09
Gross Margin -165.02% Profit Margin - Avg. Volume 19,456 Target Price 6.00
Oper. Margin -813.31% Earnings Date - Volume 5,044 Change 2.45%
About HCW Biologics Inc.

HCW Biologics Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases in the United States. The company's lead products include HCW9218, which is in Phase 1 clinical chemo-refractory/chemo-resistant solid tumors with pancreatic, ovarian, breast, prostate, and colorectal cancers, as well as Phase 2 clinical trial with metastatic advanced stage ovarian cancer patients; and HCW9302 for autoimmune and proinflammatory diseases, such as alopecia areata diseases. It also develops HCW9201, a cell-based therapy that is in Phase I clinical trials for the treatment of patients with relapsed/refractory acute myelogenous leukemia; and HCW9206, an injectable immunotherapeutic to use as adjuvant for adoptive cell therapy in cancer treatment. HCW Biologics Inc. was incorporated in 2018 and is headquartered in Miramar, Florida.

HCW Biologics Inc. News
04/01/24 HCW Biologics Reports Fourth Quarter 2023 and Fiscal Year End Financial Results And Business Highlights
02/24/24 Rebecca Byam Bought 122% More Shares In HCW Biologics
01/25/24 Several Insiders Invested In HCW Biologics Flagging Positive News
11/14/23 HCW Biologics Reports Third Quarter 2023 Financial Results And Recent Business Highlights
11/08/23 Investigator Sponsor of HCW Biologics’ Phase 1 Clinical Trial Presented Human Data Readout and Anti-Cancer Mechanism of Action of HCW9218 at 38th SITC Annual Meeting
11/01/23 Masonic Cancer Center, University of Minnesota to Present Data in Poster Presentation Human Data Readout for Phase 1 Study to Evaluate HCW9218 in Solid Tumors at SITC 38th Annual Meeting
09/16/23 Insider Buying: CFO Rebecca Byam Acquires 5,000 Shares of HCW Biologics Inc
09/14/23 Insider Buying: CFO Rebecca Byam Acquires 10,000 Shares of HCW Biologics Inc
09/06/23 HCW Biologics Participating at H.C. Wainwright 25th Annual Global Investment Conference in New York on September 11 – 13, 2023
08/18/23 Insider Stock Buying Reaches US$845k On HCW Biologics
08/11/23 HCW Biologics Reports Second Quarter 2023 Financial Results and Recent Business Highlights
07/07/23 The past year for HCW Biologics (NASDAQ:HCWB) investors has not been profitable
06/14/23 HCW Biologics is Granted Third Fundamental Patent: U.S. Patent for Methods of Treating Age-Related Disorders
05/10/23 HCW Biologics First Quarter 2023 Earnings: US$0.14 loss per share (vs US$0.057 loss in 1Q 2022)
05/09/23 HCW Biologics Reports First Quarter 2023 Financial Results And Recent Business Highlights
04/27/23 HCW Biologics Secures $26.25 Million Non-Dilutive Financing With Asset-Backed Development Loan
HCWB Chatroom

User Image VrtcIl Posted - 6 days ago

Do not chase $HCWB and wait for consolidations to enter with defined risk. Monitoring the chart during consolidation phases can offer more controlled and calculated trades. Price: 1.9 Float: 17.8M Short Float: 0.1 % 💰 Dollar Volume: 7.8K ℹ️ USA | Biotechnology

User Image Stocks4thought Posted - 6 days ago

$HCWB Watching

User Image letsgooooo111 Posted - 2 weeks ago

$HCWB hate this stock

User Image Stock_Titan Posted - 2 weeks ago

$HCWB HCW Biologics Reports Fourth Quarter 2023 and Fiscal Year End Financial Results And Business Highlights https://www.stocktitan.net/news/HCWB/hcw-biologics-reports-fourth-quarter-2023-and-fiscal-year-end-ih4736zoi9cz.html

User Image letsgooooo111 Posted - 4 weeks ago

$HCWB is it time?

User Image ChiefOG Posted - 1 month ago

$HCWB 😎

User Image letsgooooo111 Posted - 1 month ago

$HCWB BOOM! Go baby, go!

User Image letsgooooo111 Posted - 1 month ago

$HCWB so, what’s driving this up?

User Image SentimentHighStockUp Posted - 02/23/24

$HCWB

User Image SentimentHighStockUp Posted - 02/23/24

$HCWB what insider buying, wow!

User Image letsgooooo111 Posted - 01/31/24

$HCWB Get ready, go time!

User Image ReggieSanchez Posted - 01/22/24

$HCWB

User Image Last10K Posted - 3 months ago

$HCWB just filed with the SEC a Ending Agreement https://last10k.com/sec-filings/HCWB/0000950170-24-004108.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=HCWB

User Image cctranscripts Posted - 3 months ago

Termination of a Material Definitive https://www.conferencecalltranscripts.org/summary/?id=12862807 $HCWB

User Image risenhoover Posted - 3 months ago

$HCWB / HCW Biologics files form 8-K - UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 https://fintel.io/doc/sec-hcw-biologics-inc-1828673-8k-2024-january-12-19734-7263?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image tickeron Posted - 3 months ago

A.I.dvisor is predicting $HCWB is about to move higher. View odds of uptrend. https://srnk.us/go/4960471

User Image letsgooooo111 Posted - 12/21/23

$HCWB 💩🚽

User Image ChiefOG Posted - 4 months ago

$HCWB 🧐

User Image cctranscripts Posted - 4 months ago

HCW Biologics Inc.'s SVP of Business Development just picked up 7,501 shares https://www.conferencecalltranscripts.org/summary/?id=12781831 $HCWB

User Image cctranscripts Posted - 4 months ago

HCW Biologics Inc.'s See Remarks just picked up 14,000 shares https://www.conferencecalltranscripts.org/summary/?id=12781829 $HCWB

User Image cctranscripts Posted - 11/20/23

HCW Biologics Inc.'s See Remarks just picked up 15,000 shares https://www.conferencecalltranscripts.org/summary/?id=12724727 $HCWB

User Image tickeron Posted - 4 months ago

A.I.dvisor made a bearish call on $HCWB, netting in a 34.11% gain over 1 month https://srnk.us/go/4919496

User Image DollarCoins Posted - 5 months ago

$HCWB give me more under $1

User Image letsgooooo111 Posted - 5 months ago

$ATGL keep an eye on $HCWB 🚀

User Image letsgooooo111 Posted - 5 months ago

$HCWB i was buyer under a buck. Long play

User Image Skeemzz Posted - 5 months ago

$HCWB look into this one .. ATGL!! Good luck bulls

User Image Rigo7910 Posted - 5 months ago

$HCWB let’s go!

User Image MarketDataShow Posted - 5 months ago

$HCWB I'm keeping an eye on this stock for a vulture scalp. I need it to dump more hahahaha

User Image ReggieSanchez Posted - 5 months ago

$HCWB

User Image letsgooooo111 Posted - 5 months ago

$HCWB holy fork!

Analyst Ratings
EF Hutton Buy Apr 19, 23
EF Hutton Buy Mar 30, 23
EF Hutton Buy Mar 23, 23
JonesTrading Buy Nov 8, 22
Maxim Group Buy Mar 24, 22
EF Hutton Buy Nov 19, 21
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Rhode Peter See Remarks See Remarks Dec 11 Option 0.14 14,000 1,960 77,500 12/11/23
Flowers Lee SVP of Business Deve.. SVP of Business Development Dec 08 Option 0.14 7,501 1,050 118,809 12/11/23
Byam Rebecca Chief Financial Offi.. Chief Financial Officer Oct 19 Option 0.14 47,249 6,615 621,195 10/23/23
Wong Hing C Chief Executive Offi.. Chief Executive Officer Sep 14 Buy 2.0782 1,800 3,741 15,314,868 09/18/23
Winer Gary M Director Director Sep 13 Buy 2.05 1,587 3,253 17,000 09/15/23
Byam Rebecca Chief Financial Offi.. Chief Financial Officer Sep 13 Buy 2.098 5,000 10,490 573,946 09/15/23
Byam Rebecca Chief Financial Offi.. Chief Financial Officer Sep 11 Buy 2.07 10,000 20,700 568,946 09/13/23
Winer Gary M Director Director Sep 08 Buy 2 600 1,200 15,413 09/12/23
Byam Rebecca Chief Financial Offi.. Chief Financial Officer Sep 07 Buy 1.99 10,000 19,900 558,946 09/08/23
Winer Gary M Director Director Sep 05 Buy 1.85 463 857 14,813 09/07/23
Byam Rebecca Chief Financial Offi.. Chief Financial Officer Sep 06 Buy 1.9498 5,000 9,749 548,946 09/07/23
Flowers Lee SVP of Business Deve.. SVP of Business Development Jun 08 Buy 2.16 10,000 21,600 111,308 06/09/23
Flowers Lee SVP of Business Deve.. SVP of Business Development Jun 08 Option 0.14 5,356 750 101,308 06/09/23
Byam Rebecca Chief Financial Offi.. Chief Financial Officer Jun 09 Buy 2.0643 20,000 41,286 543,946 06/09/23
Byam Rebecca Chief Financial Offi.. Chief Financial Officer Jun 07 Buy 2.12 24,696 52,356 523,946 06/08/23
Wong Hing C Chief Executive Offi.. Chief Executive Officer Jun 01 Buy 1.58 1,600 2,528 15,313,068 06/02/23
Wong Hing C Chief Executive Offi.. Chief Executive Officer May 30 Buy 1.55 5,000 7,750 15,311,468 06/01/23
Winer Gary M Director Director May 30 Buy 1.51 1,350 2,038 14,350 06/01/23
Byam Rebecca Chief Financial Offi.. Chief Financial Officer May 25 Buy 1.64 40,000 65,600 460,188 05/31/23
Byam Rebecca Chief Financial Offi.. Chief Financial Officer May 22 Buy 1.57 58,486 91,823 420,188 05/24/23
Byam Rebecca Chief Financial Offi.. Chief Financial Officer Sep 12 Buy 2.61 30,000 78,300 312,952 09/14/22
Wong Hing C Chief Executive Offi.. Chief Executive Officer Sep 02 Buy 2.57 10,000 25,700 15,296,468 09/07/22
Byam Rebecca Chief Financial Offi.. Chief Financial Officer Aug 26 Buy 2.55 20,000 51,000 265,752 08/30/22
Byam Rebecca Chief Financial Offi.. Chief Financial Officer Aug 24 Buy 2.55 90,300 230,265 245,752 08/26/22
Byam Rebecca Chief Financial Offi.. Chief Financial Officer Jun 13 Buy 2.27 66,452 150,846 155,452 06/15/22
Wong Hing C Chief Executive Offi.. Chief Executive Officer Jun 10 Buy 2.188 1,520 3,326 15,286,468 06/13/22
Winer Gary M Director Director Jun 08 Buy 2.2 3,500 7,700 13,000 06/10/22
Wong Hing C Chief Executive Offi.. Chief Executive Officer Jun 07 Buy 2.28 3,000 6,840 15,284,948 06/09/22
Greene Rick S. Director Director Jun 02 Buy 2.0918 4,800 10,041 8,411 06/06/22
Rhode Peter See Remarks See Remarks Jan 14 Option 0.18 1,715 309 48,500 01/19/22